The Great Debate: What is Enough... Women in Clinical Trials

Join the FDA Office of Women’s Health for The Great Debate! Featuring Ellis F. Unger, M.D., FDA CDER, and Rita F. Redberg, M.D., M.Sc., F.A.C.C., the debate centers on cardiovascular disease clinical trials and the challenges and complexity of the question “What is enough?”, when determining participation of women in these trials. FDA Commissioner, Scott Gottlieb, M.D., will provide the Keynote in celebration of National Women’s Health Week.

• Scott Gottlieb M.D., Commissioner of Food and Drugs
• Ellis F. Unger M.D., Cardiologist and Director of the Office of Drug Evaluation-I, Office of New Drugs (OND), Center for Drug Evaluation and Research (CDER), U.S. FDA.
• Rita F. Redberg M.D., Cardiologist and Professor of Medicine, UCSF and Chief Editor of JAMA Internal Medicine

• FDA Office of Women's Health